Lv2
200 积分 2023-10-27 加入
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report
4天前
已完结
Phase II One Arm Multicenter Study of Early Reinfusion of Tisagenlecleucel to Promote Durable B-cell Aplasia in Pediatric and Young Adult Patients with relapsed/refractory CD19-Positive B-cell Acute Lymphoblastic Leukemia (REFUEL)
5天前
已关闭
Cytokine‐Engineered Chimeric Antigen Receptor‐T Cell Therapy: How to Balance the Efficacy and Toxicity
7天前
已关闭
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
7天前
已完结
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer
12天前
已完结
Improving cure rates of B-cell acute lymphoblastic leukemia with chimeric antigen receptor T-cells
13天前
已完结
Phase 1 trial of HS006, a recombinant human-mouse chimeric anti-CD20 monoclonal antibody to treat CD20 positive B-cell non-Hodgkin's lymphoma in China
18天前
已关闭
Phase 1 trial of HS006, a recombinant human-mouse chimeric anti-CD20 monoclonal antibody to treat CD20 positive B-cell non-Hodgkin's lymphoma in China
18天前
已关闭
Rituximab maintenance therapy in indolent NHL: a clinical review
19天前
已完结
Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review
19天前
已完结
皖公网安备34019202002308
